BL

Boston Life Science Venture

Asia, T'ai-pei, Taiwan, Taipei

Description

Boston Life Science Venture Co. specializes in seed to late stage, expansion stage, and growth stage.

Investor Profile

Boston Life Science Venture has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (40%)
  • Series Unknown (20%)
  • Series B (20%)
  • Series C (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Biopharma
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Boston Life Science Venture frequently co-invest with?

DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 2
Pac-Link
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 2
EV
Asia, Fujian, China, Taipei
Co-Investments: 2
CMEA Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 2
Pappas Ventures
North America, North Carolina, United States, Durham
Co-Investments: 2

What are some of recent deals done by Boston Life Science Venture?

ConforMIS

Burlington, Massachusetts, United States

ConforMIS develops personalized, patient-specific implants, and instrumentation for knee-related therapeutics.

Health CareMedical DeviceTherapeutics
Series DJul 9, 2008
Amount Raised: $14,915,000
GlobeImmune

Louisville, Colorado, United States

GlobeImmune focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.

BiotechnologyMedicalTherapeutics
Series CSep 26, 2007
Amount Raised: $41,200,000
Nereus Pharmaceuticals

San Diego, California, United States

Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.

BiotechnologyHealth CareMedical
Series DAug 9, 2007
Amount Raised: $45,000,000
Bayhill Therapeutics

Portola Valley, California, United States

Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.

BiopharmaBiotechnologyTherapeutics
Series UnknownApr 11, 2006
Amount Raised: $15,800,000
Bayhill Therapeutics

Portola Valley, California, United States

Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.

BiopharmaBiotechnologyTherapeutics
Series BMay 4, 2005
Amount Raised: $35,400,000